BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Lymphocyte
,
Pharmacogenetics
,
Lovastatin
,
rs2300478
,
VEGFA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antithyroid agent
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Broad Connectivity Map (CMAP 2.0) compound database
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Prediction for recurrence following antithyroid drug therapy for Graves' hyperthyroidism.
Predictive effect of antithyroid antibody for relapse of Graves' disease.
Clinical characteristics of neutropenic patients under antithyroid drug: Twelve-year experience in a…
Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a …
Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohor…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Change of Gut Microbiome in the Treatment of Graves' Disease
Iodinated Contrast Media Induced Hyperthyroidism
Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary o…
Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ